Contraception requirements in clinical HIV research: a qualitative analysis of adolescent perspectives from Malawi and Botswana

Abstract Background Clinical HIV research involving investigational or newly approved medications requires women of childbearing potential to use two forms of contraception to minimize fetal risk. These requirements also apply to adolescents who can become pregnant, yet ethical and legal guidelines rarely address their unique experiences and concerns, and little is known about whether and how such requirements influence adolescents’ participation in research. This study explores the perspectives of adolescents in Malawi and Botswana on contraception use requirements for participation in clinical HIV research. Methods We conducted in-depth interviews with adolescents aged 15 to 20 years in Botswana and Malawi who had experienced pregnancy and were either living with HIV or at risk of HIV acquisition. Participants were purposively recruited from clinics and peer support groups. Interview transcripts were coded using a collaboratively developed codebook that combined a-priori codes with codes inductively generated from detailed transcript review. Thematic analysis was applied to identify patterns and emergent themes in perceived advantages and disadvantages of requiring contraception use for participation in clinical HIV research. Results A total of 80 adolescents were interviewed (40 living with HIV, 40 at risk of HIV acquisition). Participants’ mean age was 17.8 years (SD = 1.2). 60% were single and about a quarter (26.3%) reported having a non-cohabitating partner. The mean age at the first pregnancy was 16.9 years (SD = 1.4). Most (72.5%) expressed support for contraception requirements. Participants described three perceived advantages of requiring two forms of contraception for clinical HIV research participation: prevention of pregnancy via required contraceptive use, protection from HIV and other sexually transmitted infections, and preservation of the study quality and integrity. Perceived disadvantages included concerns about side effects associated with required contraception use, lack of choice and autonomy related to the contraception requirement, and misalignment between required contraception use and current lifestyle. Conclusions Most adolescents supported requiring contraception for research participation but expressed concerns about side effects and constraints on autonomy. These findings highlight the need for approaches that support adolescents’ autonomy and reproductive choices while appropriately balancing the need to protect against potential harms of exposure to investigational medication during pregnancy.

Authors

Publication Details

Journal
BMC Women s Health
Published
2026-10-07
DOI
https://doi.org/10.1186/s12905-026-04976-0
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Contraception requirements in clinical HIV research: a qualitative analysis of adolescent perspectives from Malawi and Botswana

Kehumile Ramontshonyana, Aamirah Mussa, Annie Thom, Rita Vanessa Masese et al.
BMC Women s Health
Ethics in Clinical Research
article

Contraception requirements in clinical HIV research: a qualitative analysis of adolescent perspectives from Malawi and Botswana

Kehumile Ramontshonyana, Aamirah Mussa, Annie Thom, Rita Vanessa Masese, Ontibile Tshume, Suzanne Day, Mary Kasule, Aishah Hagan-Bezgin, Mbabi Bapabi, Agatha Kapatuka Bula, Pearson Mmodzi, Chelsea Morroni, Anne Drapkin Lyerly, Picrina Winner, Raksha Rajeshmohan, Hadas Clementine Baron
article en

Abstract

Abstract Background Clinical HIV research involving investigational or newly approved medications requires women of childbearing potential to use two forms of contraception to minimize fetal risk. These requirements also apply to adolescents who can become pregnant, yet ethical and legal guidelines rarely address their unique experiences and concerns, and little is known about whether and how such requirements influence adolescents’ participation in research. This study explores the perspectives of adolescents in Malawi and Botswana on contraception use requirements for participation in clinical HIV research. Methods We conducted in-depth interviews with adolescents aged 15 to 20 years in Botswana and Malawi who had experienced pregnancy and were either living with HIV or at risk of HIV acquisition. Participants were purposively recruited from clinics and peer support groups. Interview transcripts were coded using a collaboratively developed codebook that combined a-priori codes with codes inductively generated from detailed transcript review. Thematic analysis was applied to identify patterns and emergent themes in perceived advantages and disadvantages of requiring contraception use for participation in clinical HIV research. Results A total of 80 adolescents were interviewed (40 living with HIV, 40 at risk of HIV acquisition). Participants’ mean age was 17.8 years (SD = 1.2). 60% were single and about a quarter (26.3%) reported having a non-cohabitating partner. The mean age at the first pregnancy was 16.9 years (SD = 1.4). Most (72.5%) expressed support for contraception requirements. Participants described three perceived advantages of requiring two forms of contraception for clinical HIV research participation: prevention of pregnancy via required contraceptive use, protection from HIV and other sexually transmitted infections, and preservation of the study quality and integrity. Perceived disadvantages included concerns about side effects associated with required contraception use, lack of choice and autonomy related to the contraception requirement, and misalignment between required contraception use and current lifestyle. Conclusions Most adolescents supported requiring contraception for research participation but expressed concerns about side effects and constraints on autonomy. These findings highlight the need for approaches that support adolescents’ autonomy and reproductive choices while appropriately balancing the need to protect against potential harms of exposure to investigational medication during pregnancy.

BMC Women s Health
Openalex Percentile: Top 9%
Ethics in Clinical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.